dr. verma discusses challenges with biosimilars in oncology
Published 6 years ago • 100 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
1:29
dr. verma discusses biosimilars in the oncology sphere
-
1:05
dr. verma discusses combinations with biosimilars
-
0:59
dr. verma discusses biosimilars for trastuzumab
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
0:59
dr. verma discusses the approval process for biosimilars
-
3:33
biosimilars: manufacturing and inherent variation
-
56:36
understanding the challenges of universal biomarker testing
-
54:02
biocon biologics' management on acquiring biosimilars business of viatris
-
1:48
dr. markman on the concept of biosimilars in oncology
-
2:12
dr. verma on incorporating biosimilars into practice
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
5:56
the complexity of choosing biosimilars in oncology
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
1:20
dr. savin on the challenges of developing biosimilar clinical trials
-
0:53
dr. schmid on evaluating biosimilars in oncology
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
0:58
dr. hurvitz on the clinical use of biosimilars in oncology
-
0:45
dr. preeshagul on education for biosimilars in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology